Miragen Therapeutics, Inc.
They are a clinical-stage biopharmaceutical company discovering and developing proprietary RNA-targeted therapeutics with a specific focus on microRNAs and their roles in diseases where there is a high unmet medical need.
$8.60 - $6.52
February 9, 2018
Jefferies, Evercore ISI, Deutsche Bank
To view the prospectus for Miragen Therapeutics, Inc. IPO, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277